Please ensure Javascript is enabled for purposes of website accessibility Contrarian Fund - Janus Henderson Investors
For Institutional Investors in the US

Contrarian Fund Holdings

Full Portfolio Holdings

(As of May 31, 2024)

% OF INVESTMENTS
Caesars Entertainment Inc 4.73
Vertiv Holdings Co 4.72
Teleflex Inc 4.26
Crown Holdings Inc 3.96
Marvell Technology Inc 3.92
Sempra 3.87
Amazon.com Inc 3.85
Oracle Corp 3.78
PNC Financial Services Group Inc 3.62
Advanced Micro Devices Inc 3.48
American Electric Power Co Inc 3.39
Chart Industries Inc 3.12
Freeport-McMoRan Inc 2.93
AbbVie Inc 2.92
Occidental Petroleum Corp 2.86
Howmet Aerospace Inc 2.49
Capital One Financial Corp 2.42
Western Alliance Bancorp 2.35
Workday Inc 2.34
Surgery Partners Inc 2.28
Wynn Resorts Ltd 2.14
Intercontinental Exchange Inc 2.04
Core & Main Inc 2.02
Constellium SE 2.00
Globus Medical Inc 1.94
Catalent Inc 1.90
Sotera Health Co 1.88
Cullen/Frost Bankers Inc 1.72
Argenx SE (ADR) 1.68
Madrigal Pharmaceuticals Inc 1.62
3M Co 1.52
Signet Jewelers Ltd 1.48
Ferguson PLC 1.46
Dell Technologies Inc 1.41
Galderma Group AG 1.11
Beauty Health Co, 1.25%, 10/01/26 1.10
Amicus Therapeutics Inc 1.08
Lantheus Holdings Inc 1.02
Vaxcyte Inc 0.94
Bloom Energy Corp 0.73
Sportradar Group AG 0.70
Beauty Health Co 0.53
AST SpaceMobile Inc 0.49
MRVL US 21Jun24 Call (AMERICAN PHYSICAL) JPM OTC 90 0.00
VRT US 21Jun24 Call (AMERICAN PHYSICAL) GS OTC 120 -0.01
CZR US 21Jun24 Put (AMERICAN PHYSICAL) CITI OTC 32.5 -0.01
DELL US 21Jun24 Put (AMERICAN PHYSICAL) MS OTC 125 -0.04
Cash & Equivalents 0.26
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.